dc.contributor.author | Budanov, Andrei | en |
dc.date.accessioned | 2020-02-21T15:38:40Z | |
dc.date.available | 2020-02-21T15:38:40Z | |
dc.date.issued | 2020 | en |
dc.date.submitted | 2020 | en |
dc.identifier.citation | Segal?s J, Perdiguero E, Serrano AL, Sousa-Victor P, Ortet L, Jardi M, Budanov A, Garcia-Prat L, Sandri M, Thomson D, Karin M, Lee JH, and Munoz-Canoves P., Sestrin prevents muscle atrophy from disuse and aging by integrating anabolic and catabolic signals., Nature Communications, 11, 1, 2020, 189- | en |
dc.identifier.other | Y | en |
dc.description | PUBLISHED | en |
dc.description.abstract | A unique property of skeletal muscle is its ability to adapt its mass to changes in activity.
Inactivity, as in disuse or aging, causes atrophy, the loss of muscle mass and strength, leading
to physical incapacity and poor quality of life. Here, through a combination of transcriptomics
and transgenesis, we identify sestrins, a family of stress-inducible metabolic regulators, as
protective factors against muscle wasting. Sestrin expression decreases during inactivity and
its genetic deficiency exacerbates muscle wasting; conversely, sestrin overexpression suffices
to prevent atrophy. This protection occurs through mTORC1 inhibition, which upregulates
autophagy, and AKT activation, which in turn inhibits FoxO-regulated ubiquitin–proteasomemediated
proteolysis. This study reveals sestrin as a central integrator of anabolic and
degradative pathways preventing muscle wasting. Since sestrin also protected muscles
against aging-induced atrophy, our findings have implications for sarcopenia. | en |
dc.format.extent | 189 | en |
dc.language.iso | en | en |
dc.relation.ispartofseries | Nature Communications | en |
dc.relation.ispartofseries | 11 | en |
dc.relation.ispartofseries | 1 | en |
dc.rights | Y | en |
dc.subject | Sestrin | en |
dc.subject | Muscle atrophy | en |
dc.subject | Sarcopenia | en |
dc.title | Sestrin prevents muscle atrophy from disuse and aging by integrating anabolic and catabolic signals. | en |
dc.type | Journal Article | en |
dc.type.supercollection | scholarly_publications | en |
dc.type.supercollection | refereed_publications | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/budanova | en |
dc.identifier.rssinternalid | 212916 | en |
dc.identifier.doi | http://dx.doi.org/10.18632/oncotarget.27367 | en |
dc.rights.ecaccessrights | openAccess | |
dc.relation.source | Journal Webpage | en |
dc.subject.TCDTheme | Ageing | en |
dc.subject.TCDTheme | Cancer | en |
dc.subject.TCDTag | Metabolism | en |
dc.relation.sourceuri | https://www.nature.com/articles/s41467-019-13832-9 | en |
dc.identifier.orcid_id | 0000-0002-7943-1000 | en |
dc.subject.darat_impairment | Age-related disability | en |
dc.subject.darat_thematic | Health | en |
dc.status.accessible | N | en |
dc.identifier.uri | https://www.nature.com/articles/s41467-019-13832-9 | |
dc.identifier.uri | http://hdl.handle.net/2262/91606 | |